Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2012        Go!    
 
 
November 22, Wednesday 2017 9:12 AM       

       HEADLINES: Purchasing laptop under IT@school: Laptop price reduced by Rs 455                                              One arrested in connection with attack on Mayor                                              There was no pressure: Justice P S Antony                                              Clashes in Munnar hartal, CPI not participating                                              ‘Honey trap’ case against A K Saseendran: Commission submits report                                              ‘Padmavati’ row: Kamal wants Deepika’s head 'saved'                                              Indian Army breaks world record with 58 men on single bike                                              IFFI 2017: Sridevi inaugurates Indian Panorama                                              Finally, Robert Mugabe resigns                                              Kohli climbs to fifth spot in Test rankings                                              Sindhu leads India's challenge at Hong Kong Open                                              India vs SL: Bhuvi, Dhawan released from team                                              Kaumudi Facebook
       SCI&TECH Next Article: Clearing the myths about osteoporosis  
       Aspirin a day may keep liver cancer away
 
         Posted on :18:27:33 Oct 21, 2017
   
A A
       Last edited on:18:27:33 Oct 21, 2017
         Tags: Aspirin a day may keep liver cancer away
 

WASHINGTON DC: Taking aspirin daily can reduce the risk of liver cancer, a new study suggested.

The researchers found that everyday aspirin therapy could significantly associate with a reduced risk in hepatitis B related liver cancer.

Hepatitis B is a viral infection that attacks the liver. HBV can be contracted through contact with an infected person's blood or other bodily fluid, and the infection can either be acute or chronic.

It has been estimated that around estimated 240 million people worldwide have chronic HBV. The findings also show Africa and Asia as the highest prevalence of the virus.

Previous studies also show that daily aspirin therapy -- which is often prescribed to prevent cardiovascular disease -- may also prevent the development of cancer.

However, on another note clinical evidence is being lacked for the effectiveness of aspirin therapy in preventing HBV-related liver cancer.

Researcher Teng-Yu Lee from the Taichung Veterans General Hospital conducted a nationwide cohort study to determine if aspirin therapy could, indeed, reduce liver cancer risk.

"Liver cancer is the second leading cause of cancer death worldwide, and HBV is the most prevalent risk factor in our region," said Dr. Lee who's the lead author of the study.

"HBV-related liver cancer is therefore a major public health issue with a severe socioeconomic impact," he stated.

Dr. Lee stated that therapies which reduce the risk of liver cancer like, nucleos(t)ide analogue therapy, do not completely eliminate the risk. Adding, he also mentioned that most HBV carriers are not indicated for antiviral therapy, so another effective way of reducing liver cancer risk needs to be developed.

"Aspirin has been investigated to explore its chemopreventive effect in cancers that are related to chronic inflammation, particularly in the prevention of colorectal cancer. However, clinical evidence supporting the chemopreventive effect of aspirin therapy on liver cancer remains limited. Therefore, we conducted a large-scale cohort study to evaluate the association of aspirin therapy with HBV-related liver cancer," he noted.

Retrieving past medical records for the study, they screened records of 204,507 patients with chronic hepatitis B, and excluded patients with other forms of infectious hepatitis, from the National Health Insurance Research Database between the year 1998 and 2012.

The past findings showed that 1,553 patients who continuously received daily aspirin for at least 90 days were randomly matched 1:4 with 6,212 patients who had never received anti- platelet therapy by means of propensity scores consisting of baseline characteristics.

The researchers analyzed both cumulative incidents of and hazard ratios for HCC development after adjusting for competing mortality.

Cumulative incidence of liver cancer in the group treated with aspirin therapy was significantly lower than that in the untreated group in five years.

The researchers in their multivariate regression analysis found that aspirin therapy was independently associated with reduced liver cancer risk.

"For effectively preventing HBV-related liver cancer, the findings of this study may help hepatologists treat patients with chronic HBV infection in the future, particularly for those who are not indicated for antiviral therapy. We are pursuing prospective investigations for further confirming the findings," stated Dr. Lee.

The study presented at The Liver Meeting held by the American Association for the Study of Liver Diseases (AASLD).

A A
       SCI&TECH
Next Article: Clearing the myths about osteoporosis
 
 
SCI&TECH HEADLINES
How breastmilk protects babies from food allergy decoded  
Stars among the oldest in our galaxy discovered  
Apple delays release of smart speaker - HomePod  
Owning a dog may add years to your life  
'Textisms' actually add meaning to written words  
Sugar may heal wounds, says study  
Heart-stopping sex? It's rare  
Over 1.3 lakh Indians 'book ticket' to Mars  
China all set to make first contact with aliens  
Greenland Ice sheet could be losing mass, says study  
'Flying taxis' could be a thing by 2020  
When art comes to the rescue of depressed patients  
Here's a mechanism that can help you get rid of bad memories  
2017 ozone hole smallest since 1988: NASA  
Marijuana can dull the brain in some HIV patients  
We use lesser brainpower than thought  
You can soon delete 'sent messages' on WhatsApp  
There is a connection between nose and emotions  
75% of pet reptiles die within a year: Study  
Gamma rays will reach beyond limits of light: Researchers  
Suicide molecules may help combat cancer: Study  
Aspirin a day may keep liver cancer away  
Clearing the myths about osteoporosis  
Stress as unhealthy as junk food  
Planet Nine does exist in solar system: NASA  
 
Do you think media was banned at CM's office on Tuesday?
yes
 
no
 
no opinion
 
 
 
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]kaumudi.com
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy